Interestingly, SLUG and vimentin promote cell migration and invasion through the upregulation of a receptor tyrosine kinase Axl in breast cancer cells35, and the overexpression of Axl also correlates with poor prognosis in OSCC patients36. The gene discussed is NTRK1; the disease is breast cancer.